levothyroxine sodium 0.2 MG Injection
- RxCUI
- 1115269
- RxNorm name
- levothyroxine sodium 0.2 MG Injection
- Display name
- Levothyroxine (Injectable)
- Full name
- levothyroxine sodium 0.2 MG Injection
- Term type
- SCD
- Status
- Active
- Strength
- 0.2 mg
- Dose form
- Injection
- Route
- Injectable
- Updated
- 2026-11-04 11:50:57
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082011
- Active start
- 082011
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| levothyroxine sodium | 0.2 MG / 1 EACH | levothyroxine | levothyroxine sodium |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| levothyroxine | 10582 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | levothyroxine sodium 0.2 MG Injection | 1 | NAMES |
| RxNorm Name | levothyroxine sodium 0.2 MG Injection | 1 | NAMES |
| RxNorm Synonym | levothyroxine sodium 200 MCG Injection | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 6 | CODES | |
| RxCUI | 1115269 | 1 | CODES |
| MMSL_CODE | 4 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 25021-469-10 | 25021-469 | Levothyroxine Sodium Levothyroxine Sodium Anhydrous | Sagent Pharmaceuticals | ANDA208749 |
| 42023-202-01 | 42023-202 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | ENDO USA, Inc. | NDA202231 |
| 63323-647-10 | 63323-647 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | NDA202231 |
| 70511-112-10 | 70511-112 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | ANDA208749 |
| 70710-1834-1 | 70710-1834 | LEVOTHYROXINE SODIUM levothyroxine sodium | Zydus Pharmaceuticals USA Inc. | ANDA217066 |
| 83270-007-01 | 83270-007 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | ONESOURCE SPECIALTY PHARMA LIMITED | ANDA216729 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA208749 | 25021-469 | Levothyroxine Sodium Levothyroxine Sodium Anhydrous | ANDA | Sagent Pharmaceuticals |
| NDA202231 | 42023-202 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | NDA | ENDO USA, Inc. |
| ANDA217066 | 70710-1834 | LEVOTHYROXINE SODIUM levothyroxine sodium | ANDA | Zydus Pharmaceuticals USA Inc. |
| ANDA216729 | 83270-007 | Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS | ANDA | ONESOURCE SPECIALTY PHARMA LIMITED |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | ONESOURCE SPECIALTY PHARMA LIMITED | ae9954a5-e196-449c-abea-ebe4afbee517 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 83270-007-01 83270-007 83270000701 1115269 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | MAIA Pharmaceuticals, Inc. | 4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | 70511-112-10 70511-112 70511011210 1115269 |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Zydus Pharmaceuticals USA Inc. | bf8a952c-f05b-4814-b55a-ed04be015269 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 70710-1834-1 70710-1834 70710183401 1115269 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | ENDO USA, Inc. | 9d815416-11c9-470e-a82f-89b0bf232e12 | 2025-04-28 | Boxed warning, Warnings, Adverse reactions | 42023-202-01 42023-202 42023020201 1115269 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | ce990712-49c1-4f66-9ee4-c770e8ec394c | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 63323-647-10 63323-647 63323064710 1115269 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Sagent Pharmaceuticals | f57e9b19-6f17-4520-80fc-511322cc56c9 | 2023-10-19 | Boxed warning, Warnings, Adverse reactions | 25021-469-10 25021-469 25021046910 1115269 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ce990712-49c1-4f66-9ee4-c770e8ec394c | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | 20250417 |
| 9d815416-11c9-470e-a82f-89b0bf232e12 | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | 20250428 |
| bf8a952c-f05b-4814-b55a-ed04be015269 | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for Injection, for intravenous use Initial U.S. Approval: 1969 | 20250916 |
| 4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | 20190130 |
| ae9954a5-e196-449c-abea-ebe4afbee517 | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | 20250526 |
| f57e9b19-6f17-4520-80fc-511322cc56c9 | levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | 20231019 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| ce990712-49c1-4f66-9ee4-c770e8ec394c | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | Fresenius Kabi USA, LLC | 20261102 |
| ae9954a5-e196-449c-abea-ebe4afbee517 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited | 20260812 |
| 4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited | 20260805 |
| ae9954a5-e196-449c-abea-ebe4afbee517 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited | 20260327 |
| bf8a952c-f05b-4814-b55a-ed04be015269 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for Injection, for intravenous use Initial U.S. Approval: 1969 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20250916 |
| ae9954a5-e196-449c-abea-ebe4afbee517 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited | 20250526 |
| 9d815416-11c9-470e-a82f-89b0bf232e12 | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | ENDO USA, Inc. | Fresenius Kabi USA, LLC | 20250428 |
| ce990712-49c1-4f66-9ee4-c770e8ec394c | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | Fresenius Kabi USA, LLC | 20250417 |
| 9f652cbf-a3f5-4b7e-a5fd-a902c6ead389 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | Athenex Pharmaceutical Division, LLC. | 20240304 |
| f57e9b19-6f17-4520-80fc-511322cc56c9 | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | Sagent Pharmaceuticals | 20231019 |
| 6e77ac5a-6404-2556-e053-2991aa0a92e6 | Levothyroxine Sodium for Injection These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. LEVOTHYROXINE sodium for injection, for intravenous use Initial U.S. Approval: 1969 | Piramal Critical Care, Inc. | Fresenius Kabi, LLC | 20191224 |
| 4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd | These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969 | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited | 20190130 |
| 7820d23f-17e8-448c-8a40-c3278831fe8e | These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969 | Par Pharmaceutical Companies, Inc. | 20151211 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | H03AA | Thyroid hormones | ATC1-4 | levothyroxine sodium | |
| FDASPL | D013974 | Thyroxine | CHEM | has_chemical_structure | levothyroxine |
| FDASPL | N0000175945 | l-Thyroxine | EPC | has_epc | levothyroxine |
| MEDRT | D013974 | Thyroxine | CHEM | has_ingredient | levothyroxine sodium |
| MEDRT | D013974 | Thyroxine | CHEM | has_ingredient | levothyroxine |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | levothyroxine |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levothyroxine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | levothyroxine |
| MEDRT | D006042 | Goiter | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | levothyroxine |
| MEDRT | D007037 | Hypothyroidism | DISEASE | may_prevent | levothyroxine sodium |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | levothyroxine |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D009230 | Myxedema | DISEASE | may_treat | levothyroxine |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | levothyroxine |
| MEDRT | D013959 | Thyroid Diseases | DISEASE | may_diagnose | levothyroxine sodium |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | levothyroxine |
| MEDRT | D013964 | Thyroid Neoplasms | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013967 | Thyroiditis, Autoimmune | DISEASE | may_treat | levothyroxine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | levothyroxine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | levothyroxine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | may_treat | levothyroxine sodium |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | levothyroxine |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | levothyroxine |
| MEDRT | N0000000237 | Thyroid Hormone Receptor Agonists | MOA | has_moa | levothyroxine sodium |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | levothyroxine |
| MEDRT | N0000008347 | Cellular Synthetic Activity Alteration | PE | has_pe | levothyroxine sodium |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | levothyroxine |
| MEDRT | N0000009340 | Increased Gluconeogenesis | PE | has_pe | levothyroxine sodium |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | levothyroxine |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | levothyroxine sodium |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.2 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA208749 |
| CODES | ANDA | ANDA216729 |
| CODES | ANDA | ANDA217066 |
| CODES | NDA | NDA202231 |
| CODES | VUID | 4002325 |
| NAMES | Prescribable Synonym | levothyroxine sodium 200 MCG Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |